EIT Health Investors Network: a key opportunity for start-ups in search of funding

by GENESIS Biomed

4 years ago
Asebio Investor Day, start-ups, funds, EIT Health Investors

AseBio Investor Day’s round table on fundraising in Europe gathered EIT Health Investor Network’s main stakeholders

Aortyx gana el premio Alex Casta

by GENESIS Biomed

4 years ago
digital health, Aortyx, IQS Tech Factory, Àlex Casta, GENESIS Biomed, startup

Aortyx, apoyada en su origen por IQS Tech Factory, ha sido la startup más votada en la final de los Premis Àlex Casta como mejor pitch de la Bioregión. La startup fundada y dirigida por Jordi Ma...

Having a good understanding with your team is essential: they will make your company grow

by GENESIS Biomed

4 years ago
investors, company, Caixaimpulse, Catapult de EIT Health, Aortyx

At the end of last year Aortyx secured the biggest financing round of the sector (650K) without Venture Capitals or crowdfunding platforms. This start-up from Institut Químic de Sarrià’s (IQS) S

Marta Barrachina: 'I am confident that there will be advances in Alzheimer’s in the short term'

by GENESIS Biomed

4 years ago
diagnostic test, healthcare, ADmit Therapeutics, Alzheimer, Marta Barrachina

Despite the Covid-19 pandemic, 2020 has been a great year for ADmit Therapeutics, a spin-off from Bellvitge Biomedical Research Institute (IDIBELL, in Barcelona) born at the end of 2017 and leaded by ...

The great entrepreneurship moment of Madrid healthcare ecosystem

by GENESIS Biomed

4 years ago
entrepreneurship, healthcare, spin-off, ITEMAS, Corify Care, Telara Pharmaceuticals, POSITIVE

In the last 18 months 4 new hospital spin-off have been approved with the support of GENESIS Biomed

Joan Roca: 'As chefs we have a great responsibility'

by GENESIS Biomed

4 years ago
children’s obesity, Joan Roca, LiverScreen, nutrition, liver fibrosis, health education

The prominent chef Joan Roca, main chef at El Celler de Can Roca, is the ambassador of LiverScreen, a research program that aims to reduce mortality caused by liver diseases. It will analyse how an ea...

A sector in good shape despite the Covid-19 pandemic

by GENESIS Biomed

4 years ago
ITEMAS, private investment, healthcare, ASABYS Partners, Invivo Capital, ASEBIO, GENESIS Biomed, GENESIS Ventures

ITEMAS last webinar showed the optimism of healthcare investors

Covid-19: first-hand experiences from entrepreneurs

by GENESIS Biomed

4 years ago
telecommuting, entrepreneurs, covid-19, start-up, teletrabajo, Admit Therapeutics, Aortyx, Corify, Cornea, CreatSens, Oxolife

The SARS-CoV-2 pandemic that is hitting many countries has clearly affected the medical start-up and spin-off ecosystem. After talking to some of the companies we support we have seen that it has not ...

A solid science and the right patent, keys to raise private funding

by GENESIS Biomed

4 years ago
solid science, patent, funding, health, ITEMAS, CORIFY CARE, GLYCARDIAL, APTATARGETS

Having a solid scientific project and the right patent to protect it are key to raise funding in health innovation projects, according to the three entrepreneurs that participated in the 3rd webinar o...

The keys to raise private funding: evaluation of an innovation project

by GENESIS Biomed

4 years ago
investor, Ysios Capital, private funding, innovation, ITEMAS, competition, Arvor Global Management

Raising private funding is essential for an innovation project to progress and reach market. ITEMAS 2nd webinar of the series about Investment in Covid-19 times tackled the key steps for entrepreneurs...

A key tool for the future of Alzheimer’s disease research

by GENESIS Biomed

4 years ago
Alzheimer, neurogenerative, artificial intelligence, Pasqual Maragall Foundation

Doctor Juan Domingo Gispert and his team, from Barcelona Beta Brain Research Center, work in a tool to improve the selection of patients for Alzheimer’s prevention studies

ITEMAS is in favour of the creation of a fund or investment instrument for early stage projects

by GENESIS Biomed

4 years ago
industrial property, fund, early stage, ITEMAS, medical centres, investment

Which are the needs of innovation projects born in medical centres? Which are the limitations to bring them to market? Innovation experts gave their views at the 1st ITEMAS webinar about “Investm...